🇪🇪 Estonia · EU Public Tender
Ravimid tsefoksitiin, ipilimumab, okrelizumab ja immuunoglobuliin intravaskulaarseks kasutamiseks
🏛️ sihtasutus Põhja-Eesti Regionaalhaigla · 📍 Tallinn
1.5M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Roche Eesti Osaühing |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.